1[1]Fritz H, Wunderer G. Biochemistry and applications of approtinin, the kallikrein inhibitor from boving organs[J]. Arzneimittelforschung, 1983,33(4) :479 - 494.
2[2]Miller BE, Tosone SR, Tam VKH, et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operation[ J] .Ann Thorac Surg, 1998,66(3):535 - 540.
3[3]Porte R J, Molenaar IQ, Begliomini B. Aprotinin and transfusion requirement in orthotopic liver transplantation: a multicentre randomized double-blind study [ J ]. Lancet, 2000,355(9 212): 1 303 - 1 309.
4[4]Asimakopoulos G, Thompson R, Nourshargh S, et al. An antiinflammatory property of aprotinin detected at the level of leukocyte extravasation [J]. J Thorac Cardiovasc Surg, 2000,120(2) :361 - 369.
6[6]Davidson BR, Burnett S, Javed MS, et al. Experimental study of a novel fibrin sealant for achieving haemostasis following partial hepatectomy[ J]. Br J Surg, 2000,87(6) :790 - 795.
7[7]Born P, Ott R, Rosch T. Endoscopic hemostasis using fibrin sealant for postsphinct erotomy bleeding: report of two case [ J ]. Gastrointest Endosc, 2000,51 (6): 731 - 733.
8[8]Holcomb JB, McClain JM, Pusateri AE, et al. Fibrin sealant foam sprayed directlyon liver injuries decrease blood loss in resuscitated rats[J] .J Trauma,2000,49(2):246- 250.
9[9]Scheule AM, Jurmann MJ, Wended HP, et al. Anaphylactic shock after aprotinin reexposure: time course of aprotinin-specific antibodies[J]. Ann Thorac Surg, 1997,63 (3): 242 -244.
10[10]Scheule AM, Beierlein W, Lorenz H, et al. Repeated anaphylactic reaction to aprotinin in fibrin sealant [J]. Gastrointest Endosc, 1998,48( 1 ) :83 - 85.
